A high bar for health tech startups
Venture capital investors at Fortune's recent Brainstorm Health summit gave a tough, but encouraging prognosis for health tech startups.
Stay updated with breaking news from Soleus Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Venture capital investors at Fortune's recent Brainstorm Health summit gave a tough, but encouraging prognosis for health tech startups.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51.
– Significantly Strengthened Balance Sheet in January 2024 with Execution of Three-Tranche Private Placement of up to $240 Million, Extending Cash Runway Into the Third Quarter of 2025 Based on...
$20.4 million in upfront financing with the potential to receive up to an additional approximately $34.2 million for an aggregate of up to approximately $55 million Upfront net proceeds to provide...